It is currently Wed May 23, 2012 6:13 am

 * Register   * Login  | Unanswered | Active topics | Tags list by forum




   Forum locked This topic is locked, you cannot edit posts or make further replies.      Page 1 of 1
  [ 3 posts ]  Bookmark and Share Oldest Best Reply
  Print view Previous topic | First unread post | Next topic 
Author Message
x97agarwal
  Bold Face - CR [#permalink]
New postPosted: Sat Jun 07, 2008 9:26 am 
Offline
Senior Manager
Senior Manager

Joined: Tue May 23, 2006
Posts: 351
Followers: 2

Kudos (?): 32 (0), given: 0

GMAT Tests User
A double-blind study, in which neither the patient nor the primary researcher knows whether the patient is being given the drug being tested or a placebo, is the most effective procedure for testing the efficacy of a drug. But we will not be able to perform such a study on this new drug, since the drug will have various effects on the patients’ bodies, which will make us aware of whether the patients are getting the drug or a placebo.
The two portions in boldface play which of the following roles? (A) The first is a general consideration that introduces the argument; the second is a special situation that weighs against the first.
(B) The first is a general principle that is necessary for this argument; the second is an anti-consideration that the argument includes.
(C) The first is a premise that this argument includes; the second is a main idea that can be drawn from this argument.
(D) The first is an evidence that this argument includes; the second is a conclusion that can not be drawn from this argument.
(E) The first is a general situation that supports this argument; the second is a conclusion that can be drawn from a special fact.


  Profile  
 
chouchou
  Re: Bold Face - CR [#permalink]
New postPosted: Wed Jun 11, 2008 6:39 pm 
Offline
Intern
Intern
User avatar

Joined: Tue Apr 08, 2008
Posts: 15
Followers: 0

Kudos (?): 3 (0), given: 0
I would pick b)

Argument: We can't do a double blind study
Reason/Evidence: We'll be able to tell if the real medication was administered based on the presence of a reaction to the drug

a)The first is a general consideration that introduces the argument (the first part doesn't introduce the argument); the second is a special situation that weighs against the first.
b)The first is a general principle that is necessary for this argument (tells you how double-blind studies work); the second is an anti-consideration that the argument includes (explains why we can't do it)
c) The first is a premise that this argument includes; the second is a main idea that can be drawn from this argument (Argument is located in the second part).
d)The first is an evidence that this argument includes (the first part describes how double-blinds work--it makes no assertions); the second is a conclusion that can not be drawn from this argument.
e)The first is a general situation that supports this argument (description doesn't explain why a double blind isn't possible); the second is a conclusion that can be drawn from a special fact.

What is the answer?


  Profile  
 
ncp
  Re: Bold Face - CR [#permalink]
New postPosted: Wed Jun 11, 2008 7:09 pm 
Offline
SVP
SVP
User avatar

Joined: Wed Nov 08, 2006
Posts: 1582
Location: Ann Arbor
Schools: Ross '10
Followers: 10

Kudos (?): 150 (0), given: 1

GMAT Tests User
Please stop posting verbal questions in this forum. Post them on the Verbal forum. Any more CRs posted will be deleted immediately.


  Profile  
 
Online
gmatclubot
Display posts from previous:  Sort by  

Forum locked This topic is locked, you cannot edit posts or make further replies.  Page 1 of 1
  [ 3 posts ] 



Who is online

Users browsing this forum: No registered users and 1 guest

Search for:
Jump to:





[ Mobile Version ] GMAT Club MBA Forum Home | About | Privacy Policy | Terms and Conditions | GMAT Club Rules | Contact | Sitemap
Powered by phpBB © phpBB Group and phpBB SEO
Kindly note that GMAT (C) is a registered trademark of the Graduate Management Admission Council, and this site has neither been reviewed nor endorsed by GMAC.